YU42893A - Inhibitori hiv proteaze korisni za tretiranje aids-a - Google Patents

Inhibitori hiv proteaze korisni za tretiranje aids-a

Info

Publication number
YU42893A
YU42893A YU42893A YU42893A YU42893A YU 42893 A YU42893 A YU 42893A YU 42893 A YU42893 A YU 42893A YU 42893 A YU42893 A YU 42893A YU 42893 A YU42893 A YU 42893A
Authority
YU
Yugoslavia
Prior art keywords
alkyl
heterocycle
aryl
cycloalkyl
unsaturated heterocycle
Prior art date
Application number
YU42893A
Other languages
English (en)
Inventor
J.E. Munroe
W.J. Hornback
Original Assignee
Eli Lilly And Company Indianapolis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company Indianapolis filed Critical Eli Lilly And Company Indianapolis
Publication of YU42893A publication Critical patent/YU42893A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01GPRELIMINARY TREATMENT OF FIBRES, e.g. FOR SPINNING
    • D01G1/00Severing continuous filaments or long fibres, e.g. stapling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • DTEXTILES; PAPER
    • D02YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
    • D02GCRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
    • D02G3/00Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
    • D02G3/02Yarns or threads characterised by the material or by the materials from which they are made
    • DTEXTILES; PAPER
    • D02YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
    • D02JFINISHING OR DRESSING OF FILAMENTS, YARNS, THREADS, CORDS, ROPES OR THE LIKE
    • D02J1/00Modifying the structure or properties resulting from a particular structure; Modifying, retaining, or restoring the physical form or cross-sectional shape, e.g. by use of dies or squeeze rollers
    • D02J1/22Stretching or tensioning, shrinking or relaxing, e.g. by use of overfeed and underfeed apparatus, or preventing stretch
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • D06M13/322Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
    • D06M13/402Amides imides, sulfamic acids
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M7/00Treating fibres, threads, yarns, fabrics, or fibrous goods made of other substances with subsequent freeing of the treated goods from the treating medium, e.g. swelling, e.g. polyolefins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M2200/00Functionality of the treatment composition and/or properties imparted to the textile material
    • D06M2200/40Reduced friction resistance, lubricant properties; Sizing compositions
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2331/00Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
    • D10B2331/02Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyamides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Textile Engineering (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Peptides Or Proteins (AREA)

Abstract

INHIBITORI HIV PROTEAZE KORISNI ZA TRETIRANJE AIDS-A, pronalaskom je dat postupak za dobijanje jedinjenja formule 1 gde: R je C1-C6 alik, cikloalkil, hetrocikl, nezasićeni heterocikl, aril, cikloalkil (C1-C4) alkil, heterocikl (C1-C4) alkil, nezasićeni heterocikl (C1-C4) alkil, aril (C1-C4) alkil, ili struktura formule -A- (CH2)q-R0, gde A je -O-, -NH-, ili -S-q je 0, 1, 2 ili 3; R0 je cikloalkil, aril, heterocikl ili nezasićeni heterocikl; X je gde: R1 je aril, cikloalkil, heterocikl ili nezasićeni heterocikl; R2 je vodonik, ili C1-C4; R3 je aminokiselinski bočni niz, -CH2CH3, -CH2CH2CH3, -CH2(CH2)2CH3, -C(CH3)3, cijano (C1-C4) alkil, nezasićeni heterocikl (C1-C4)alkil, aril (C1-C4) alkil ili struktura formule -(CH2)s- A0-(CH2)R-R4 ili -CH2-C(O)-NR2(CH2)R-R5, gde s je 1,2,3 ili 4; R je 0,1,2 ili 3; A0 je -O-, -NH- ili -S-; R4 je C1-C6 alkil, cikloalkil, aril, heterocikl, ili nezasićeni heterocikl; R5 je cikloalkil, aril, heterocikl ini nezasićeni heterocikl; j je 0,1,2,3 ili 4; k je 0 ili 1; i Y je -O-, -N(R2)- ili -S-; ili njegova farmaceutski prihvaljiva so. Dobijena jedinjenja imaju farmaceutsku aktivnost i naročito su pogodna za tretiranje obolelih od AIDS-a.
YU42893A 1992-06-19 1993-06-21 Inhibitori hiv proteaze korisni za tretiranje aids-a YU42893A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90144792A 1992-06-19 1992-06-19

Publications (1)

Publication Number Publication Date
YU42893A true YU42893A (sh) 1996-07-24

Family

ID=25414213

Family Applications (1)

Application Number Title Priority Date Filing Date
YU42893A YU42893A (sh) 1992-06-19 1993-06-21 Inhibitori hiv proteaze korisni za tretiranje aids-a

Country Status (21)

Country Link
US (1) US5578608A (sh)
EP (1) EP0575097B1 (sh)
JP (1) JP3195462B2 (sh)
KR (2) KR940005620A (sh)
CN (1) CN1082035A (sh)
AU (1) AU663958B2 (sh)
BR (1) BR9302389A (sh)
CA (1) CA2098165A1 (sh)
CO (1) CO4130200A1 (sh)
CZ (1) CZ113393A3 (sh)
DE (1) DE69329606T2 (sh)
ES (1) ES2152241T3 (sh)
FI (1) FI932847A (sh)
HU (1) HUT67571A (sh)
IL (1) IL105973A0 (sh)
MX (1) MX9303572A (sh)
NO (1) NO932130L (sh)
NZ (1) NZ247837A (sh)
PL (1) PL299369A1 (sh)
TW (1) TW218873B (sh)
YU (1) YU42893A (sh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9306058A (pt) 1992-03-11 1997-11-18 Narhex Ltd Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
ZA945719B (en) * 1993-08-09 1996-02-01 Lilly Co Eli Identification and use of protease inhibitors
EP0812839A1 (en) * 1994-12-08 1997-12-17 LG Chemical Limited Irreversible HIV protease inhibitors, compositions containing same and process for the preparation thereof
US5696134A (en) * 1993-11-30 1997-12-09 Lg Chemical Limited Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
KR0125117B1 (ko) * 1994-06-15 1997-12-05 성재갑 항 에이즈(aids)효과를 갖는 신규한 인간 면역 결핍 바이러스(hiv)프로테아제 억제 화합물 및 그의 제조방법
KR0159652B1 (ko) * 1995-10-26 1998-12-01 성재갑 항 에이즈 효과를 갖는 비가역적 인간 면역 결핍 바이러스 프로테아제 저해제 및 그의 제조방법
US5693847A (en) * 1995-04-19 1997-12-02 Vertex Pharmaceuticals Incorporated Heteroatom functionalized α-methyl ketones
US7431956B2 (en) 2003-06-20 2008-10-07 Sensient Imaging Technologies, Inc. Food grade colored fluids for printing on edible substrates
BRPI0511926B1 (pt) 2004-06-10 2014-08-12 Sensient Imaging Technologies Fluido colorido de grau alimentício, processo de aplicação de um colorante comestível a uma superfície de um substrato comestível e substrato comestível
US9113647B2 (en) 2008-08-29 2015-08-25 Sensient Colors Llc Flavored and edible colored waxes and methods for precision deposition on edible substrates
WO2014075676A1 (en) * 2012-11-15 2014-05-22 V-Biotek Holding Aps Amines from trigonella foemum - graecum

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5142056A (en) * 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
JPS60193979A (ja) * 1984-03-15 1985-10-02 Mitsui Toatsu Chem Inc Ν−(ω−グリシドキシアルキル)置換アミド化合物及びその製造方法
US5155227A (en) * 1984-07-19 1992-10-13 University Of Florida Compounds for site-enhanced delivery of radionuclides
FR2582514B1 (fr) * 1985-05-30 1988-02-19 Rhone Poulenc Sante Medicaments a base d'amides, nouveaux amides et leur preparation
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
EP0361341A3 (en) * 1988-09-28 1991-07-03 Miles Inc. Therapeutics for aids based on inhibitors of hiv protease
AU8320691A (en) * 1990-07-06 1992-02-04 Smithkline Beecham Corporation Inhibitors of retroviral proteases
IE913840A1 (en) * 1990-11-20 1992-05-20 Abbott Lab Retroviral protease inhibiting compounds
CN1071930A (zh) * 1991-07-10 1993-05-12 伊莱利利公司 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂

Also Published As

Publication number Publication date
PL299369A1 (en) 1993-12-27
DE69329606T2 (de) 2001-05-03
CN1082035A (zh) 1994-02-16
CA2098165A1 (en) 1993-12-20
NO932130L (no) 1993-12-20
KR940005620A (ko) 1994-03-21
JP3195462B2 (ja) 2001-08-06
CO4130200A1 (es) 1995-02-13
HUT67571A (en) 1995-04-28
NZ247837A (en) 1995-04-27
FI932847A (fi) 1993-12-20
ES2152241T3 (es) 2001-02-01
CZ113393A3 (en) 1994-03-16
KR940000634A (ko) 1994-01-03
BR9302389A (pt) 1994-01-11
AU663958B2 (en) 1995-10-26
FI932847A0 (fi) 1993-06-18
JPH0656812A (ja) 1994-03-01
EP0575097B1 (en) 2000-11-02
AU4135493A (en) 1993-12-23
US5578608A (en) 1996-11-26
TW218873B (sh) 1994-01-11
EP0575097A1 (en) 1993-12-22
IL105973A0 (en) 1993-10-20
NO932130D0 (no) 1993-06-10
HU9301795D0 (en) 1993-09-28
MX9303572A (es) 1994-01-31
DE69329606D1 (de) 2000-12-07

Similar Documents

Publication Publication Date Title
YU42893A (sh) Inhibitori hiv proteaze korisni za tretiranje aids-a
FI906204A0 (fi) Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
DE3766198D1 (de) Bizyklische aromatische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
FI950309A (fi) Proliiniamidijohdannaisia
EA200200708A1 (ru) Производные бензазола и их применение в качестве модуляторов jnk
RU94040859A (ru) Аминопроизводные оксо- и гидрокси-замещенных углеводородов, способы получения, фармацевтические композиции, способ ингибирования ретровирусной протеазы, способ лечения спида у млекопитающих
ATE448194T1 (de) Verwendung einer pharmazeutischen zusammensetzung mit einem para-aminophenylessigsäurederivat für die behandlung von entzündlichen erkrankungen des magen-darmtrakts
ES455089A1 (es) Procedimiento de preparacion de nuevas oximas derivadas del acido 7-aminotioazolil-acetamido-cefalosporanico.
DZ1694A1 (fr) "n-(2-Aminoethyl)-benzothialozones".
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
ES2095976T3 (es) Compuestos de pirazolopiridina y procedimiento para su preparacion.
DE69727915D1 (de) Substituierte vinylpyridinderivate und arzneimittel, die diese enthalten
ATE153666T1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
DK0630252T3 (da) Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme
YU67792A (sh) Inhibitori hiv proteaze korisni za lečenje aids
KR910011259A (ko) 뉴모시스토시스 치료 또는 예방에 사용하기 위한 플루오로퀴놀론 유도체로 구성된 약제
ES8300094A1 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
DK0712838T3 (da) Acylphenylglycinderivat og forebyggende middel og lægemiddel til sygdomme, der er forårsaget af en forøget kollagenaseaktiv
SE8802066D0 (sv) N-imidazolyl derivatives of bicyclic compounds useful in medicine
ES8200103A1 (es) Un procedimiento para la preparacion de una ftalazina
SE9401965D0 (sv) New compounds
GB1136918A (en) Propanolamine derivatives
RU94033470A (ru) Циклогексановые производные, фармкомпозиция на их основе и способ лечения
ATE5584T1 (de) N-substituierte brenztraubensaeurehydrazone, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten.
DE59309898D1 (de) 4-oxo-azetidin-2-sulfonsäureamide und ihre salze, verfahren zu deren herstellung und ihre verwendung